author-photo

Joost W. J. van Esser

Erasmus University Medical Center

11

Papers

1209

Citations

Citation Trend

Filter By

Papers (11) Sort By

Journal Conference Others

Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial

2021 Blood Advances
Show All
- Source
- Cite
- Save
Citations (5)
Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84)

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (10)
EBV reactivation and lymphoproliferative disease transplantation may identify patients at very high risk for progressive lymphocytes after partially T-depleted allogeneic stem cell specific CD8+ T -- Impaired recovery of Epstein-Barr virus (EBV)

2013
Show All
- Source
- Cite
- Save
Citations (0)
T-cell-depleted stem cell transplantation allogeneic patients despite highly effective prevention of CMV disease after Increased transplant-related morbidity and mortality in CMV-seropositive

2010
Show All
- Source
- Cite
- Save
Citations (0)
Fatal pulmonary tumour embolism as initial manifestation of an occult coecum tumour

2009 Nederlands Tijdschrift voor Geneeskunde
- Nicole C.H.P. van der Burg-de Graauw
- Joost W. J. van Esser
Show All
- Source
- Cite
- Save
Citations (0)
Associations among Epstein-Barr Virus Subtypes, Human Leukocyte Antigen Class I Alleles, and the Development of Posttransplantation Lymphoproliferative Disorder in Bone Marrow Transplant Recipients

2007 Clinical Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (7)
Impaired recovery of Epstein-Barr virus (EBV)-specific CD8+T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease

2003 Blood
Show All
- Source
- Cite
- Save
Citations (133)
Prevention of Epstein-Barr virus–lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation

2002 Blood
Show All
- Source
- Cite
- Save
Citations (353)
Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT

2001 Blood
Show All
- Source
- Cite
- Save
Citations (323)
Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein-Barr virus-associated lymphoproliferative disease after allogeneic stem cell transplantation

2001 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (93)